Renalytix Number Of Shares Shorted vs. Market Capitalization

RNLX Stock  USD 0.16  0.01  6.67%   
Based on the key profitability measurements obtained from Renalytix's financial statements, Renalytix AI may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Renalytix's ability to earn profits and add value for shareholders. Price To Sales Ratio is likely to drop to 11.26 in 2024. Days Sales Outstanding is likely to drop to 82.42 in 2024. At this time, Renalytix's Income Tax Expense is fairly stable compared to the past year. Change To Netincome is likely to rise to about 5.7 M in 2024, despite the fact that Accumulated Other Comprehensive Income is likely to grow to (1.4 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.06470.0682
Notably Down
Slightly volatile
For Renalytix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Renalytix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Renalytix AI utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Renalytix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Renalytix AI over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renalytix. If investors know Renalytix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renalytix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.042
Quarterly Revenue Growth
0.131
Return On Assets
(0.94)
Return On Equity
(10.73)
The market value of Renalytix AI is measured differently than its book value, which is the value of Renalytix that is recorded on the company's balance sheet. Investors also form their own opinion of Renalytix's value that differs from its market value or its book value, called intrinsic value, which is Renalytix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renalytix's market value can be influenced by many factors that don't directly affect Renalytix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renalytix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Renalytix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renalytix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Renalytix AI Market Capitalization vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Renalytix's current stock value. Our valuation model uses many indicators to compare Renalytix value to that of its competitors to determine the firm's financial worth.
Renalytix AI is rated below average in number of shares shorted category among its peers. It is rated below average in market capitalization category among its peers creating about  59.51  of Market Capitalization per Number Of Shares Shorted. At this time, Renalytix's Market Cap is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Renalytix's earnings, one of the primary drivers of an investment's value.

Renalytix Market Capitalization vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Renalytix

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
378.92 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Renalytix

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
22.55 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Renalytix Market Capitalization vs Competition

Renalytix AI is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 20.7 Billion. Renalytix adds roughly 22.55 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Total debt  Valuation  Workforce  Revenue

Renalytix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Renalytix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Renalytix will eventually generate negative long term returns. The profitability progress is the general direction of Renalytix's change in net profit over the period of time. It can combine multiple indicators of Renalytix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-1.4 M-1.4 M
Net Loss-41 M-39 M
Net Interest Income585.4 K556.1 K
Interest Income585.4 K556.1 K
Operating Income-29.6 M-31.1 M
Net Loss-33.5 M-35.1 M
Income Before Tax-33.5 M-35.1 M
Total Other Income Expense Net-3.8 M-3.7 M
Net Loss-33.5 M-35.1 M
Income Tax ExpenseK4.2 K
Change To Netincome4.7 M5.7 M
Net Loss(0.31)(0.32)
Income Quality 0.90  0.91 
Net Income Per E B T 1.00  0.95 

Renalytix Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Renalytix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Renalytix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Renalytix's important profitability drivers and their relationship over time.

Use Renalytix in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Renalytix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Renalytix will appreciate offsetting losses from the drop in the long position's value.

Renalytix Pair Trading

Renalytix AI Pair Trading Analysis

The ability to find closely correlated positions to Renalytix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Renalytix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Renalytix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Renalytix AI to buy it.
The correlation of Renalytix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Renalytix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Renalytix AI moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Renalytix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Renalytix position

In addition to having Renalytix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Management Thematic Idea Now

Health Management
Health Management Theme
Major hospitals and healthcare providers. The Health Management theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.